Growing community of inventors

Tokyo, Japan

Kenta Oono

Average Co-Inventor Count = 2.86

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 16

Kenta OonoRyosuke Okuta (4 patents)Kenta OonoSeiya Tokui (4 patents)Kenta OonoYuya Unno (4 patents)Kenta OonoDaisuke Okanohara (3 patents)Kenta OonoNobuyuki Ota (2 patents)Kenta OonoJustin Clayton (2 patents)Kenta OonoJustin B Clayton (1 patent)Kenta OonoNobuyuki Ota (1 patent)Kenta OonoKenta Oono (10 patents)Ryosuke OkutaRyosuke Okuta (13 patents)Seiya TokuiSeiya Tokui (7 patents)Yuya UnnoYuya Unno (4 patents)Daisuke OkanoharaDaisuke Okanohara (18 patents)Nobuyuki OtaNobuyuki Ota (3 patents)Justin ClaytonJustin Clayton (2 patents)Justin B ClaytonJustin B Clayton (6 patents)Nobuyuki OtaNobuyuki Ota (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Preferred Networks, Inc. (10 from 76 patents)


10 patents:

1. 12423622 - Generative machine learning systems for generating structural information regarding chemical compound

2. 12079729 - Information processing device and information processing method

3. 12026620 - Information processing device and information processing method

4. 11921566 - Abnormality detection system, abnormality detection method, abnormality detection program, and method for generating learned model

5. 11915146 - Information processing device and information processing method

6. 11900225 - Generating information regarding chemical compound based on latent representation

7. 11521070 - Information processing device and information processing method

8. 11334407 - Abnormality detection system, abnormality detection method, abnormality detection program, and method for generating learned model

9. 10831577 - Abnormality detection system, abnormality detection method, abnormality detection program, and method for generating learned model

10. 10776712 - Generative machine learning systems for drug design

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/2/2026
Loading…